Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatocellular Carcinoma
100%
Liver Transplantation
95%
Hepatitis C Virus
60%
Fibrosis
54%
Liver
53%
Hepatic Stellate Cells
50%
Cirrhosis
45%
Liver Fibrosis
40%
HIV-infected Patients
40%
Hepatic Stellate Cell Activation
37%
Hepatic Fibrosis
37%
Hepatitis C
34%
Nonalcoholic Steatohepatitis
33%
Liver Disease
32%
Ribavirin
30%
United States
25%
Antifibrotic
24%
Non-alcoholic Fatty Liver Disease (NAFLD)
23%
Chronic Liver Disease
23%
AIDS/HIV
23%
Sustained Virological Response
22%
Liver Injury
22%
Chronic Hepatitis C
21%
Transplantation
19%
Stellate Cells
19%
Liver Transplant Recipients
18%
Fibrogenic
17%
Direct-acting Antivirals
17%
Primary Biliary Cirrhosis
16%
Pegylated Interferon
15%
Liver Biopsy
15%
Sofosbuvir
15%
Drug-induced Liver Injury
15%
95% Confidence Interval
15%
Tumor
15%
Fibrogenesis
14%
Hepatocytes
14%
Antiretroviral Therapy
14%
Metabolic Dysfunction-associated Steatohepatitis
13%
Post-liver Transplant
13%
Risk Factors
13%
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
13%
Transforming Growth Factor-β
13%
Hepatitis B Virus
12%
Hepatitis C Virus Infection
12%
Resection
12%
Clinical Trials
12%
Kidney Transplant Recipients
12%
Extracellular Matrix
12%
Hepatitis B
12%
Apoptosis
11%
Interferon-α (IFN-α)
11%
Hepatic Fibrogenesis
11%
Immunosuppression
11%
Steatohepatitis
11%
Pretransplant
11%
Hepatitis C Virus Genotypes
10%
Response Rate
10%
COVID-19
10%
Hepatology
10%
Chronic Hepatitis B
9%
Autophagy
9%
Liver Resection
9%
Stellate Cell Activation
9%
Kidney Transplantation
9%
Krüppel-like Factor 6
9%
Advanced Fibrosis
9%
Acute Liver Failure
8%
Inflammation
8%
Patient Outcomes
8%
Liver Cancer
8%
Primary Sclerosing Cholangitis
8%
Tumor Suppressor Gene
8%
Steatosis
8%
Placebo
8%
Transplant Recipients
8%
Belatacept
8%
Immune Checkpoint Inhibitors
8%
Graft Survival
7%
Tumor Suppressor
7%
Single Center
7%
Gene Expression
7%
Carbon Tetrachloride
7%
Acute Liver Injury
7%
Mount Sinai
7%
HIV/hepatitis C Virus Coinfection
7%
Etiology
7%
Downstaging
7%
Patients with HIV
7%
Combination Therapy
7%
Kidney
7%
Virus Hepatitis
7%
Portal Hypertension
7%
Hepatitis C Virus Treatment
7%
Gene Signature
7%
Meta-analysis
7%
Viral Hepatitis
7%
Resmetirom
7%
Cirrhotic Patients
6%
Orthotopic Liver Transplantation
6%
Medicine and Dentistry
Liver Transplantation
92%
Hepatocellular Carcinoma
91%
Fibrosis
43%
Liver Fibrosis
38%
Liver Graft
35%
Liver Disease
34%
Liver Cirrhosis
32%
Nonalcoholic Fatty Liver
31%
Diseases
29%
Hepatic Stellate Cell
26%
Liver Injury
25%
Human Immunodeficiency Virus
22%
Hepatectomy
20%
Recurrent Disease
18%
Fibrogenesis
17%
Hepatitis C Virus
17%
Living Donors
16%
Neoplasm
16%
Liver Cancer
15%
Chronic Liver Disease
14%
Hepatitis C
14%
Liver Biopsy
13%
Cholangiocarcinoma
12%
Stellate Cell
12%
Allograft
11%
Portal Hypertension
11%
Malignant Neoplasm
11%
Tumor
11%
Magnetic Resonance Imaging
11%
Toxic Hepatitis
11%
Immunosuppressive Treatment
11%
Pathogenesis
10%
Cell Activation
10%
Hepatology
10%
Infection
10%
Morbidity
10%
Graft Survival
10%
Biopsy Technique
10%
Inflammation
9%
Kidney Graft
9%
Hepatocyte
9%
Clinical Trial
9%
Hepatitis B Virus
9%
Fatty Liver
9%
COVID-19
9%
Kidney Transplantation
9%
Primary Biliary Cirrhosis
9%
Milan Criteria
8%
Metabolic Dysfunction-Associated Steatotic Liver Disease
8%
Etiology
8%
Extracellular Matrix
8%
Biological Marker
8%
Steatosis
8%
Immunotherapy
7%
Metabolic Dysfunction-Associated Steatohepatitis
7%
Steatohepatitis
7%
Chronic Hepatitis C
7%
Pediatrics
7%
Overall Survival
7%
Hepatitis Virus
7%
Primary Sclerosing Cholangitis
6%
Survival Rate
6%
Acute Liver Failure
6%
Prevalence
6%
Hazard Ratio
6%
Genetics
6%
Immune Checkpoint Inhibitor
6%
Ischemia
6%
Bilirubin
5%
Decompensated Liver Cirrhosis
5%
Graft Failure
5%
Machine Perfusion
5%
Hepatitis B
5%
Cancer
5%
Sofosbuvir
5%
Intestinal Transplantation
5%
Odds Ratio
5%
Gene Expression Profiling
5%
Organ Transplantation
5%
Chronic Hepatitis B
5%
Nephrectomy
5%
Adverse Event
5%
Deceased Donors
5%
Antiviral Therapy
5%
Cytoreductive Surgery
5%
Ribavirin
5%
Alcohol Liver Disease
5%